Consumer Goods Nestlé Reportedly to Kick Off Sale of Peanut Allergy Pill PalforziaNestlé bought the maker of Palforzia in a $2.6 billion deal in 2020. March 1, 2023
Healthcare InTandem-Backed Vivo Infusion Purchases Civic InfusionCivic Infusion is focused on delivering services for infusion patients in Connecticut and New York. January 31, 2023